Mega Genomics Limited (HKG:6667)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.20
-0.05 (-0.69%)
Mar 31, 2025, 3:45 PM HKT
-20.88%
Market Cap 1.61B
Revenue (ttm) 171.61M
Net Income (ttm) 34.27M
Shares Out 224.30M
EPS (ttm) 0.17
PE Ratio 43.30
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,200
Average Volume 5,480
Open 7.30
Previous Close 7.25
Day's Range 7.20 - 7.30
52-Week Range 5.98 - 11.98
Beta 1.02
RSI 46.97
Earnings Date May 30, 2025

About Mega Genomics

Mega Genomics Limited, a genetic testing platform company, provides consumer genetic testing and cancer screening services in China. It offers general testing services, including brain health assessment package, a service that assesses the risk of various related diseases, including Alzheimer’s disease; alimentation capability assessment package, a service that assesses the risk of developing hyperhomocysteinemia; Parkinson’s disease risk assessment; full-scale cancer risk assessment packages; and cardiovascular and cerebrovascular disease risk... [Read more]

Sector Healthcare
Founded 2016
Employees 229
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6667
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.